Microarrays Overview
- Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
23
- Latest Deal Type
-
Debt - PPP
- Financing Rounds
-
2
Microarrays General Information
Description
Developer of array-based technologies intended to assist in the areas of biological research, detection and diagnostics. The company's technologies develop array-based technologies that can be used for analyte testing & diagnostics, identification of viral and bacterial pathogens and personalized medicine, enabling clients to upgrade their research methods.
Contact Information
Website
www.microarrays.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
- HudsonAlpha Institute, 601 Genome Way
- Suite 3300
- Huntsville, AL 35806
- United States
+1 (256) 000-0000
Microarrays Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Microarrays Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Joel Peek Ph.D | Chief Executive Officer | ||
| Mark McQuain | Chief Technology Officer | ||
| M. Scott | Vice President of Operations |
Microarrays Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Microarrays Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|